International Finance Facility for Immunisation: building a financial lifeline from the world’s investors to its poorest children
Every year, 22 million children miss out on vaccines against common diseases. 1.5 million die from easily-preventable diseases
Shortage of secure, predictable funding stops developing countries planning long-term health programmes for their children
IFFIm was set-up in 2006 to accelerate the availability and predictability of funds for immunisation programmes
IFFIm raises finance by issuing 'vaccine bonds' in capital markets, converting long-term government pledges into immediate cash
UK, France, Italy, Norway, Australia, Spain, the Netherlands, Sweden, South Africa have committed US$ 6.3 billion to IFFIm over 23 years
IFFIm funds help Gavi, the Vaccine Alliance. In 12 years, Gavi has prevented over 6 million future deaths
IFFIm funds catalyse uptake of vaccines against diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b
IFFIm funds strengthen immunisation and health service delivery through health worker training and support for cold chain and logistics
IFFIm supports polio and yellow fever vaccines, measles mortality reduction, maternal & neonatal tetanus
Thanks to IFFIm, Gavi has been able to nearly double its support for vaccine introduction in developing countries since 2006
27 November 2014
International Finance Facility for Immunisation issues first Sukuk, raising US$ 500 million
Funding to support immunisation of children in the poorest countries through Gavi.
08 November 2013
IFFIm rating action by Standard and Poor's follows France downgrade
Standard & Poor’s downgrades the long-term credit rating of the International Finance Facility for Immunisation (IFFIm) from AA+ to AA with a stable outlook. The short-term rating on IFFIm remains unchanged at A-1+.
27 June 2013
IFFIm issues US$ 700 million in 3-year floating rate Vaccine Bonds
The International Finance Facility for Immunisation Company (IFFIm) today announced its inaugural US dollar floating rate benchmark. The US$ 700 million, 3-year Vaccine Bonds provide investors an opportunity to fund immunisation programmes by the GAVI Alliance, helping protect millions of children in the world's poorest countries against preventable diseases.
7 August 2014Moody’s credit opinion
1 May 2014FitchRatings report
20 December 2013FitchRatings update
6 Dec 2013Moody's credit analysis
8 Nov 2013S&P rating action
How IFFIm vaccine support helps protect Haiti’s children
How the capital markets can save lives
Social impact investment
Learn more about IFFIm
IFFIm press releases
Learn how IFFIm has played a critical role in polio eradication with a US$ 191 million investment.
US$ 1.2 billion for Gavi-eligible countries has increased global uptake of new & underused vaccines.
Download presentation on IFFIm
Get a PDF of the latest IFFIm brochure
Read the June 2011 IFFIm Evaluation documents
Gavi, the Vaccine Alliance was set-up in 2000 to save children's lives and
protect people's health by increasing access to immunisation in
US$ 2.3 billion of disbursements have nearly doubled expenditures on health for Gavi, the Vaccine Alliance.
To date, nine donors have pledged US$ 6.3 billion to IFFIm over 23 years.
Download IFFIm Update no.9
© IFFIm 2014
modal window here